Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Adenocarcinoma × Gemcitabine × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5 Breast Neoplasms 4 Urothelial Cancer 2 Urinary Bladder Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasm Metastasis 2 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer 1 Non Small Cell Lung Cancer NSCLC 1 Nasopharyngeal Carcinoma 1 Metastatic Urothelial Cancer 1 Metastatic Adenocarcinoma of the Pancreas 1 Gallbladder Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma 1 Bile Duct Neoplasms 1

Interventions

zolbetuximab 2 Oxaliplatin 2 Afatinib 2 trastuzumab deruxtecan 1 tepotinib 1 repotrectinib 1 pralsetinib 1 brigatinib 1 Standard of Care 1 Pemetrexed 1 Leucovorin 1 Fluorouracil 1 Crizotinib 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡